Hantech Bio-Technology Co., Ltd. (TPEX:1294)
Taiwan · Delayed Price · Currency is TWD 76.70
-1.20 (-1.54%)
Jan 22, 2026, 1:30 PM CST
Hantech Bio-Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 132.42 | 155.67 | 148.12 | 47.47 | 32.56 | 55.77 | Upgrade |
Depreciation & Amortization | 33.7 | 30.35 | 19.44 | 18.86 | 18.24 | 14.44 | Upgrade |
Other Amortization | 2.86 | 1.72 | 1.5 | 0.47 | 0.46 | 0.25 | Upgrade |
Loss (Gain) From Sale of Assets | - | 0.35 | 0.11 | 0.55 | 0 | 1.1 | Upgrade |
Stock-Based Compensation | 0.1 | 1.03 | 0.05 | 0.17 | 4.22 | 7.57 | Upgrade |
Provision & Write-off of Bad Debts | -0 | -0.03 | -0.56 | 0.61 | -1.05 | 0.33 | Upgrade |
Other Operating Activities | -4.5 | -7.07 | 20.99 | 7.75 | -14.59 | 12.64 | Upgrade |
Change in Accounts Receivable | -9.35 | 7.94 | -37.82 | -25.73 | 6.81 | -7.53 | Upgrade |
Change in Inventory | -14.34 | 13.76 | -50.08 | -9.72 | 1.46 | -6.37 | Upgrade |
Change in Accounts Payable | 33.76 | -52.85 | 65.47 | 20.05 | -2.73 | 5.33 | Upgrade |
Change in Other Net Operating Assets | 10.04 | -0.13 | 24.68 | 2.69 | -0.98 | 27.3 | Upgrade |
Operating Cash Flow | 184.68 | 150.75 | 191.91 | 63.18 | 44.39 | 110.84 | Upgrade |
Operating Cash Flow Growth | 31.54% | -21.44% | 203.76% | 42.33% | -59.95% | 270.10% | Upgrade |
Capital Expenditures | -22.24 | -24.63 | -293.94 | -82.88 | -79.26 | -103.6 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 1.83 | 0.11 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -1.7 | -0.76 | -3.28 | -0.74 | -1.06 | -0.32 | Upgrade |
Investment in Securities | -81.89 | - | -1.2 | - | - | - | Upgrade |
Other Investing Activities | 0.01 | 0.01 | 0.96 | -0.57 | 0.56 | 0.7 | Upgrade |
Investing Cash Flow | -105.82 | -25.38 | -295.63 | -84.07 | -79.76 | -103.23 | Upgrade |
Short-Term Debt Issued | - | 5 | 9 | 10 | 4 | 20 | Upgrade |
Long-Term Debt Issued | - | 42.21 | 269.32 | 26.34 | 55.53 | 63 | Upgrade |
Total Debt Issued | 47.21 | 47.21 | 278.32 | 36.34 | 59.53 | 83 | Upgrade |
Short-Term Debt Repaid | - | -5 | -10 | -13 | - | -20 | Upgrade |
Long-Term Debt Repaid | - | -215.44 | -57.72 | -58.45 | -14.24 | -9.95 | Upgrade |
Total Debt Repaid | -185.84 | -220.44 | -67.72 | -71.45 | -14.24 | -29.95 | Upgrade |
Net Debt Issued (Repaid) | -138.63 | -173.23 | 210.6 | -35.11 | 45.29 | 53.05 | Upgrade |
Issuance of Common Stock | 29.08 | 282.4 | 2.07 | 44.63 | 3.17 | - | Upgrade |
Common Dividends Paid | -87.43 | -19.42 | -16.84 | - | -8.06 | -3.72 | Upgrade |
Other Financing Activities | - | - | - | - | - | 4.9 | Upgrade |
Financing Cash Flow | -266.35 | 89.75 | 195.83 | 9.52 | 40.4 | 54.23 | Upgrade |
Foreign Exchange Rate Adjustments | 0.01 | 0.21 | -0.05 | 0 | -0.4 | -0.23 | Upgrade |
Net Cash Flow | -187.5 | 215.33 | 92.05 | -11.37 | 4.63 | 61.61 | Upgrade |
Free Cash Flow | 162.43 | 126.13 | -102.03 | -19.7 | -34.87 | 7.23 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | -73.56% | Upgrade |
Free Cash Flow Margin | 22.63% | 16.85% | -16.32% | -6.51% | -14.51% | 2.71% | Upgrade |
Free Cash Flow Per Share | 5.29 | 4.31 | -3.60 | -0.76 | -1.44 | 0.31 | Upgrade |
Cash Interest Paid | 1.44 | 3.44 | 1.42 | 0.31 | 0.83 | 0.71 | Upgrade |
Cash Income Tax Paid | 40.04 | 47.43 | 15.49 | 5.13 | 21.14 | 1.78 | Upgrade |
Levered Free Cash Flow | 127.92 | 88.6 | -139.37 | -32.65 | -42.65 | -10.08 | Upgrade |
Unlevered Free Cash Flow | 129.81 | 91.96 | -138.05 | -31.74 | -41.68 | -9.44 | Upgrade |
Change in Working Capital | 20.11 | -31.28 | 2.25 | -12.7 | 4.55 | 18.74 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.